Funder
Key Technologies Research and Development Program
Capital Health Research and Development of Special Fund
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Liang Z, Zhou Z, Yang S et al (2021) Can patients with low-risk prostate cancer really benefit from radical treatment?: a systematic review and network meta-analysis. Andrologia 53:e14122. https://doi.org/10.1111/and.14122
2. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.
3. Hayashi N, Osaka K, Muraoka K et al. (2020) Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis. World J Urol 38: 2477-2484. doi: https://doi.org/10.1007/s00345-019-03056-3
4. Giberti C, Chiono L, Gallo F et al. (2009) Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol 27: 607–612. doi:https://doi.org/10.1007/s00345-009-0418-9
5. Hamdy FC, Donovan JL, Lane JA et al. (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. New Engl J Med 375: 1415–1424. doi:https://doi.org/10.1056/NEJMoa1606220